Global Blood Product Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Blood Product market size is predicted to grow from US$ 34560 million in 2025 to US$ 54170 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.
Blood Products are medical products derived from human blood and used for the treatment of various conditions. They include whole blood, blood components like red blood cells, platelets, and plasma, as well as plasma derivatives such as clotting factors and immunoglobulins. Blood products are essential in medical treatments, including surgeries, trauma care, and for patients with blood disorders, anemia, or immune deficiencies.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.
LPI (LP Information)' newest research report, the “Blood Product Industry Forecast” looks at past sales and reviews total world Blood Product sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Product sales for 2025 through 2031. With Blood Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Product industry.
This Insight Report provides a comprehensive analysis of the global Blood Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Product.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Product market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Blood Product market size is predicted to grow from US$ 34560 million in 2025 to US$ 54170 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.
Blood Products are medical products derived from human blood and used for the treatment of various conditions. They include whole blood, blood components like red blood cells, platelets, and plasma, as well as plasma derivatives such as clotting factors and immunoglobulins. Blood products are essential in medical treatments, including surgeries, trauma care, and for patients with blood disorders, anemia, or immune deficiencies.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.
LPI (LP Information)' newest research report, the “Blood Product Industry Forecast” looks at past sales and reviews total world Blood Product sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Product sales for 2025 through 2031. With Blood Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Product industry.
This Insight Report provides a comprehensive analysis of the global Blood Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Product.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Product market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Albumin
- Immunoglobulin
- Clotting Factor
- Others
- Hospital
- Retail Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Product Market Size (2020-2031)
2.1.2 Blood Product Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Blood Product by Country/Region (2020, 2024 & 2031)
2.2 Blood Product Segment by Type
2.2.1 Albumin
2.2.2 Immunoglobulin
2.2.3 Clotting Factor
2.2.4 Others
2.3 Blood Product Market Size by Type
2.3.1 Blood Product Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Blood Product Market Size Market Share by Type (2020-2025)
2.4 Blood Product Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Blood Product Market Size by Application
2.5.1 Blood Product Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Blood Product Market Size Market Share by Application (2020-2025)
3 BLOOD PRODUCT MARKET SIZE BY PLAYER
3.1 Blood Product Market Size Market Share by Player
3.1.1 Global Blood Product Revenue by Player (2020-2025)
3.1.2 Global Blood Product Revenue Market Share by Player (2020-2025)
3.2 Global Blood Product Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BLOOD PRODUCT BY REGION
4.1 Blood Product Market Size by Region (2020-2025)
4.2 Global Blood Product Annual Revenue by Country/Region (2020-2025)
4.3 Americas Blood Product Market Size Growth (2020-2025)
4.4 APAC Blood Product Market Size Growth (2020-2025)
4.5 Europe Blood Product Market Size Growth (2020-2025)
4.6 Middle East & Africa Blood Product Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Blood Product Market Size by Country (2020-2025)
5.2 Americas Blood Product Market Size by Type (2020-2025)
5.3 Americas Blood Product Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Product Market Size by Region (2020-2025)
6.2 APAC Blood Product Market Size by Type (2020-2025)
6.3 APAC Blood Product Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Blood Product Market Size by Country (2020-2025)
7.2 Europe Blood Product Market Size by Type (2020-2025)
7.3 Europe Blood Product Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Product by Region (2020-2025)
8.2 Middle East & Africa Blood Product Market Size by Type (2020-2025)
8.3 Middle East & Africa Blood Product Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BLOOD PRODUCT MARKET FORECAST
10.1 Global Blood Product Forecast by Region (2026-2031)
10.1.1 Global Blood Product Forecast by Region (2026-2031)
10.1.2 Americas Blood Product Forecast
10.1.3 APAC Blood Product Forecast
10.1.4 Europe Blood Product Forecast
10.1.5 Middle East & Africa Blood Product Forecast
10.2 Americas Blood Product Forecast by Country (2026-2031)
10.2.1 United States Market Blood Product Forecast
10.2.2 Canada Market Blood Product Forecast
10.2.3 Mexico Market Blood Product Forecast
10.2.4 Brazil Market Blood Product Forecast
10.3 APAC Blood Product Forecast by Region (2026-2031)
10.3.1 China Blood Product Market Forecast
10.3.2 Japan Market Blood Product Forecast
10.3.3 Korea Market Blood Product Forecast
10.3.4 Southeast Asia Market Blood Product Forecast
10.3.5 India Market Blood Product Forecast
10.3.6 Australia Market Blood Product Forecast
10.4 Europe Blood Product Forecast by Country (2026-2031)
10.4.1 Germany Market Blood Product Forecast
10.4.2 France Market Blood Product Forecast
10.4.3 UK Market Blood Product Forecast
10.4.4 Italy Market Blood Product Forecast
10.4.5 Russia Market Blood Product Forecast
10.5 Middle East & Africa Blood Product Forecast by Region (2026-2031)
10.5.1 Egypt Market Blood Product Forecast
10.5.2 South Africa Market Blood Product Forecast
10.5.3 Israel Market Blood Product Forecast
10.5.4 Turkey Market Blood Product Forecast
10.6 Global Blood Product Forecast by Type (2026-2031)
10.7 Global Blood Product Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Blood Product Forecast
11 KEY PLAYERS ANALYSIS
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Blood Product Product Offered
11.1.3 Takeda Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Blood Product Product Offered
11.2.3 CSL Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Blood Product Product Offered
11.3.3 Grifols Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Grifols Main Business Overview
11.3.5 Grifols Latest Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Blood Product Product Offered
11.4.3 Octapharma Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Octapharma Main Business Overview
11.4.5 Octapharma Latest Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Blood Product Product Offered
11.5.3 Kedrion Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Kedrion Main Business Overview
11.5.5 Kedrion Latest Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Blood Product Product Offered
11.6.3 LFB Group Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 LFB Group Main Business Overview
11.6.5 LFB Group Latest Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Blood Product Product Offered
11.7.3 Biotest Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Biotest Main Business Overview
11.7.5 Biotest Latest Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Blood Product Product Offered
11.8.3 BPL Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 BPL Main Business Overview
11.8.5 BPL Latest Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Blood Product Product Offered
11.9.3 RAAS Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 RAAS Main Business Overview
11.9.5 RAAS Latest Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Blood Product Product Offered
11.10.3 CBPO Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 CBPO Main Business Overview
11.10.5 CBPO Latest Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Company Information
11.11.2 Hualan Bio Blood Product Product Offered
11.11.3 Hualan Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Hualan Bio Main Business Overview
11.11.5 Hualan Bio Latest Developments
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Information
11.12.2 Tiantan Bio Blood Product Product Offered
11.12.3 Tiantan Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Tiantan Bio Main Business Overview
11.12.5 Tiantan Bio Latest Developments
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Information
11.13.2 Shuanglin Bio Blood Product Product Offered
11.13.3 Shuanglin Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Shuanglin Bio Main Business Overview
11.13.5 Shuanglin Bio Latest Developments
11.14 Boya Bio
11.14.1 Boya Bio Company Information
11.14.2 Boya Bio Blood Product Product Offered
11.14.3 Boya Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Boya Bio Main Business Overview
11.14.5 Boya Bio Latest Developments
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Information
11.15.2 Yuanda Shuyang Blood Product Product Offered
11.15.3 Yuanda Shuyang Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Yuanda Shuyang Main Business Overview
11.15.5 Yuanda Shuyang Latest Developments
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Information
11.16.2 Weiguang Bio Blood Product Product Offered
11.16.3 Weiguang Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Weiguang Bio Main Business Overview
11.16.5 Weiguang Bio Latest Developments
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Information
11.17.2 Nanyue Bio Blood Product Product Offered
11.17.3 Nanyue Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Nanyue Bio Main Business Overview
11.17.5 Nanyue Bio Latest Developments
11.18 KM Biologics
11.18.1 KM Biologics Company Information
11.18.2 KM Biologics Blood Product Product Offered
11.18.3 KM Biologics Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 KM Biologics Main Business Overview
11.18.5 KM Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Product Market Size (2020-2031)
2.1.2 Blood Product Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Blood Product by Country/Region (2020, 2024 & 2031)
2.2 Blood Product Segment by Type
2.2.1 Albumin
2.2.2 Immunoglobulin
2.2.3 Clotting Factor
2.2.4 Others
2.3 Blood Product Market Size by Type
2.3.1 Blood Product Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Blood Product Market Size Market Share by Type (2020-2025)
2.4 Blood Product Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Blood Product Market Size by Application
2.5.1 Blood Product Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Blood Product Market Size Market Share by Application (2020-2025)
3 BLOOD PRODUCT MARKET SIZE BY PLAYER
3.1 Blood Product Market Size Market Share by Player
3.1.1 Global Blood Product Revenue by Player (2020-2025)
3.1.2 Global Blood Product Revenue Market Share by Player (2020-2025)
3.2 Global Blood Product Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BLOOD PRODUCT BY REGION
4.1 Blood Product Market Size by Region (2020-2025)
4.2 Global Blood Product Annual Revenue by Country/Region (2020-2025)
4.3 Americas Blood Product Market Size Growth (2020-2025)
4.4 APAC Blood Product Market Size Growth (2020-2025)
4.5 Europe Blood Product Market Size Growth (2020-2025)
4.6 Middle East & Africa Blood Product Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Blood Product Market Size by Country (2020-2025)
5.2 Americas Blood Product Market Size by Type (2020-2025)
5.3 Americas Blood Product Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Product Market Size by Region (2020-2025)
6.2 APAC Blood Product Market Size by Type (2020-2025)
6.3 APAC Blood Product Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Blood Product Market Size by Country (2020-2025)
7.2 Europe Blood Product Market Size by Type (2020-2025)
7.3 Europe Blood Product Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Product by Region (2020-2025)
8.2 Middle East & Africa Blood Product Market Size by Type (2020-2025)
8.3 Middle East & Africa Blood Product Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BLOOD PRODUCT MARKET FORECAST
10.1 Global Blood Product Forecast by Region (2026-2031)
10.1.1 Global Blood Product Forecast by Region (2026-2031)
10.1.2 Americas Blood Product Forecast
10.1.3 APAC Blood Product Forecast
10.1.4 Europe Blood Product Forecast
10.1.5 Middle East & Africa Blood Product Forecast
10.2 Americas Blood Product Forecast by Country (2026-2031)
10.2.1 United States Market Blood Product Forecast
10.2.2 Canada Market Blood Product Forecast
10.2.3 Mexico Market Blood Product Forecast
10.2.4 Brazil Market Blood Product Forecast
10.3 APAC Blood Product Forecast by Region (2026-2031)
10.3.1 China Blood Product Market Forecast
10.3.2 Japan Market Blood Product Forecast
10.3.3 Korea Market Blood Product Forecast
10.3.4 Southeast Asia Market Blood Product Forecast
10.3.5 India Market Blood Product Forecast
10.3.6 Australia Market Blood Product Forecast
10.4 Europe Blood Product Forecast by Country (2026-2031)
10.4.1 Germany Market Blood Product Forecast
10.4.2 France Market Blood Product Forecast
10.4.3 UK Market Blood Product Forecast
10.4.4 Italy Market Blood Product Forecast
10.4.5 Russia Market Blood Product Forecast
10.5 Middle East & Africa Blood Product Forecast by Region (2026-2031)
10.5.1 Egypt Market Blood Product Forecast
10.5.2 South Africa Market Blood Product Forecast
10.5.3 Israel Market Blood Product Forecast
10.5.4 Turkey Market Blood Product Forecast
10.6 Global Blood Product Forecast by Type (2026-2031)
10.7 Global Blood Product Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Blood Product Forecast
11 KEY PLAYERS ANALYSIS
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Blood Product Product Offered
11.1.3 Takeda Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Blood Product Product Offered
11.2.3 CSL Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Blood Product Product Offered
11.3.3 Grifols Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Grifols Main Business Overview
11.3.5 Grifols Latest Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Blood Product Product Offered
11.4.3 Octapharma Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Octapharma Main Business Overview
11.4.5 Octapharma Latest Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Blood Product Product Offered
11.5.3 Kedrion Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Kedrion Main Business Overview
11.5.5 Kedrion Latest Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Blood Product Product Offered
11.6.3 LFB Group Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 LFB Group Main Business Overview
11.6.5 LFB Group Latest Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Blood Product Product Offered
11.7.3 Biotest Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Biotest Main Business Overview
11.7.5 Biotest Latest Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Blood Product Product Offered
11.8.3 BPL Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 BPL Main Business Overview
11.8.5 BPL Latest Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Blood Product Product Offered
11.9.3 RAAS Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 RAAS Main Business Overview
11.9.5 RAAS Latest Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Blood Product Product Offered
11.10.3 CBPO Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 CBPO Main Business Overview
11.10.5 CBPO Latest Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Company Information
11.11.2 Hualan Bio Blood Product Product Offered
11.11.3 Hualan Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Hualan Bio Main Business Overview
11.11.5 Hualan Bio Latest Developments
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Information
11.12.2 Tiantan Bio Blood Product Product Offered
11.12.3 Tiantan Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Tiantan Bio Main Business Overview
11.12.5 Tiantan Bio Latest Developments
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Information
11.13.2 Shuanglin Bio Blood Product Product Offered
11.13.3 Shuanglin Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Shuanglin Bio Main Business Overview
11.13.5 Shuanglin Bio Latest Developments
11.14 Boya Bio
11.14.1 Boya Bio Company Information
11.14.2 Boya Bio Blood Product Product Offered
11.14.3 Boya Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Boya Bio Main Business Overview
11.14.5 Boya Bio Latest Developments
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Information
11.15.2 Yuanda Shuyang Blood Product Product Offered
11.15.3 Yuanda Shuyang Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Yuanda Shuyang Main Business Overview
11.15.5 Yuanda Shuyang Latest Developments
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Information
11.16.2 Weiguang Bio Blood Product Product Offered
11.16.3 Weiguang Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Weiguang Bio Main Business Overview
11.16.5 Weiguang Bio Latest Developments
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Information
11.17.2 Nanyue Bio Blood Product Product Offered
11.17.3 Nanyue Bio Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Nanyue Bio Main Business Overview
11.17.5 Nanyue Bio Latest Developments
11.18 KM Biologics
11.18.1 KM Biologics Company Information
11.18.2 KM Biologics Blood Product Product Offered
11.18.3 KM Biologics Blood Product Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 KM Biologics Main Business Overview
11.18.5 KM Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Blood Product Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Blood Product Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Albumin
Table 4. Major Players of Immunoglobulin
Table 5. Major Players of ClottingFactor
Table 6. Major Players of Others
Table 7. Blood Product Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Blood Product Market Size byType (2020-2025) & ($ millions)
Table 9. Global Blood Product Market Size Market Share byType (2020-2025)
Table 10. Blood Product Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Blood Product Market Size Market Share by Application (2020-2025)
Table 13. Global Blood Product Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Blood Product Revenue Market Share by Player (2020-2025)
Table 15. Blood Product Key Players Head office and Products Offered
Table 16. Blood Product Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Blood Product Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Blood Product Market Size Market Share by Region (2020-2025)
Table 21. Global Blood Product Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Blood Product Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Blood Product Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Blood Product Market Size Market Share by Country (2020-2025)
Table 25. Americas Blood Product Market Size byType (2020-2025) & ($ millions)
Table 26. Americas Blood Product Market Size Market Share byType (2020-2025)
Table 27. Americas Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Blood Product Market Size Market Share by Application (2020-2025)
Table 29. APAC Blood Product Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Blood Product Market Size Market Share by Region (2020-2025)
Table 31. APAC Blood Product Market Size byType (2020-2025) & ($ millions)
Table 32. APAC Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Blood Product Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Blood Product Market Size Market Share by Country (2020-2025)
Table 35. Europe Blood Product Market Size byType (2020-2025) & ($ millions)
Table 36. Europe Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Blood Product Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Blood Product Market Size byType (2020-2025) & ($ millions)
Table 39. Middle East & Africa Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Blood Product
Table 41. Key Market Challenges & Risks of Blood Product
Table 42. Key IndustryTrends of Blood Product
Table 43. Global Blood Product Market SizeForecast by Region (2026-2031) & ($ millions)
Table 44. Global Blood Product Market Size Market ShareForecast by Region (2026-2031)
Table 45. Global Blood Product Market SizeForecast byType (2026-2031) & ($ millions)
Table 46. Global Blood Product Market SizeForecast by Application (2026-2031) & ($ millions)
Table 47.Takeda Details, CompanyType, Blood Product Area Served and Its Competitors
Table 48.Takeda Blood Product Product Offered
Table 49.Takeda Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50.Takeda Main Business
Table 51.Takeda Latest Developments
Table 52. CSL Details, CompanyType, Blood Product Area Served and Its Competitors
Table 53. CSL Blood Product Product Offered
Table 54. CSL Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. CSL Main Business
Table 56. CSL Latest Developments
Table 57. Grifols Details, CompanyType, Blood Product Area Served and Its Competitors
Table 58. Grifols Blood Product Product Offered
Table 59. Grifols Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Grifols Main Business
Table 61. Grifols Latest Developments
Table 62. Octapharma Details, CompanyType, Blood Product Area Served and Its Competitors
Table 63. Octapharma Blood Product Product Offered
Table 64. Octapharma Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Octapharma Main Business
Table 66. Octapharma Latest Developments
Table 67. Kedrion Details, CompanyType, Blood Product Area Served and Its Competitors
Table 68. Kedrion Blood Product Product Offered
Table 69. Kedrion Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Kedrion Main Business
Table 71. Kedrion Latest Developments
Table 72. LFB Group Details, CompanyType, Blood Product Area Served and Its Competitors
Table 73. LFB Group Blood Product Product Offered
Table 74. LFB Group Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. LFB Group Main Business
Table 76. LFB Group Latest Developments
Table 77. Biotest Details, CompanyType, Blood Product Area Served and Its Competitors
Table 78. Biotest Blood Product Product Offered
Table 79. Biotest Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Biotest Main Business
Table 81. Biotest Latest Developments
Table 82. BPL Details, CompanyType, Blood Product Area Served and Its Competitors
Table 83. BPL Blood Product Product Offered
Table 84. BPL Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. BPL Main Business
Table 86. BPL Latest Developments
Table 87. RAAS Details, CompanyType, Blood Product Area Served and Its Competitors
Table 88. RAAS Blood Product Product Offered
Table 89. RAAS Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. RAAS Main Business
Table 91. RAAS Latest Developments
Table 92. CBPO Details, CompanyType, Blood Product Area Served and Its Competitors
Table 93. CBPO Blood Product Product Offered
Table 94. CBPO Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. CBPO Main Business
Table 96. CBPO Latest Developments
Table 97. Hualan Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 98. Hualan Bio Blood Product Product Offered
Table 99. Hualan Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Hualan Bio Main Business
Table 101. Hualan Bio Latest Developments
Table 102.Tiantan Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 103.Tiantan Bio Blood Product Product Offered
Table 104.Tiantan Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105.Tiantan Bio Main Business
Table 106.Tiantan Bio Latest Developments
Table 107. Shuanglin Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 108. Shuanglin Bio Blood Product Product Offered
Table 109. Shuanglin Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Shuanglin Bio Main Business
Table 111. Shuanglin Bio Latest Developments
Table 112. Boya Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 113. Boya Bio Blood Product Product Offered
Table 114. Boya Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. Boya Bio Main Business
Table 116. Boya Bio Latest Developments
Table 117. Yuanda Shuyang Details, CompanyType, Blood Product Area Served and Its Competitors
Table 118. Yuanda Shuyang Blood Product Product Offered
Table 119. Yuanda Shuyang Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. Yuanda Shuyang Main Business
Table 121. Yuanda Shuyang Latest Developments
Table 122. Weiguang Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 123. Weiguang Bio Blood Product Product Offered
Table 124. Weiguang Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. Weiguang Bio Main Business
Table 126. Weiguang Bio Latest Developments
Table 127. Nanyue Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 128. Nanyue Bio Blood Product Product Offered
Table 129. Nanyue Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. Nanyue Bio Main Business
Table 131. Nanyue Bio Latest Developments
Table 132. KM Biologics Details, CompanyType, Blood Product Area Served and Its Competitors
Table 133. KM Biologics Blood Product Product Offered
Table 134. KM Biologics Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. KM Biologics Main Business
Table 136. KM Biologics Latest Developments
Table 1. Blood Product Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Blood Product Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Albumin
Table 4. Major Players of Immunoglobulin
Table 5. Major Players of ClottingFactor
Table 6. Major Players of Others
Table 7. Blood Product Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Blood Product Market Size byType (2020-2025) & ($ millions)
Table 9. Global Blood Product Market Size Market Share byType (2020-2025)
Table 10. Blood Product Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Blood Product Market Size Market Share by Application (2020-2025)
Table 13. Global Blood Product Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Blood Product Revenue Market Share by Player (2020-2025)
Table 15. Blood Product Key Players Head office and Products Offered
Table 16. Blood Product Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Blood Product Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Blood Product Market Size Market Share by Region (2020-2025)
Table 21. Global Blood Product Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Blood Product Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Blood Product Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Blood Product Market Size Market Share by Country (2020-2025)
Table 25. Americas Blood Product Market Size byType (2020-2025) & ($ millions)
Table 26. Americas Blood Product Market Size Market Share byType (2020-2025)
Table 27. Americas Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Blood Product Market Size Market Share by Application (2020-2025)
Table 29. APAC Blood Product Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Blood Product Market Size Market Share by Region (2020-2025)
Table 31. APAC Blood Product Market Size byType (2020-2025) & ($ millions)
Table 32. APAC Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Blood Product Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Blood Product Market Size Market Share by Country (2020-2025)
Table 35. Europe Blood Product Market Size byType (2020-2025) & ($ millions)
Table 36. Europe Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Blood Product Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Blood Product Market Size byType (2020-2025) & ($ millions)
Table 39. Middle East & Africa Blood Product Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Blood Product
Table 41. Key Market Challenges & Risks of Blood Product
Table 42. Key IndustryTrends of Blood Product
Table 43. Global Blood Product Market SizeForecast by Region (2026-2031) & ($ millions)
Table 44. Global Blood Product Market Size Market ShareForecast by Region (2026-2031)
Table 45. Global Blood Product Market SizeForecast byType (2026-2031) & ($ millions)
Table 46. Global Blood Product Market SizeForecast by Application (2026-2031) & ($ millions)
Table 47.Takeda Details, CompanyType, Blood Product Area Served and Its Competitors
Table 48.Takeda Blood Product Product Offered
Table 49.Takeda Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50.Takeda Main Business
Table 51.Takeda Latest Developments
Table 52. CSL Details, CompanyType, Blood Product Area Served and Its Competitors
Table 53. CSL Blood Product Product Offered
Table 54. CSL Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. CSL Main Business
Table 56. CSL Latest Developments
Table 57. Grifols Details, CompanyType, Blood Product Area Served and Its Competitors
Table 58. Grifols Blood Product Product Offered
Table 59. Grifols Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Grifols Main Business
Table 61. Grifols Latest Developments
Table 62. Octapharma Details, CompanyType, Blood Product Area Served and Its Competitors
Table 63. Octapharma Blood Product Product Offered
Table 64. Octapharma Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Octapharma Main Business
Table 66. Octapharma Latest Developments
Table 67. Kedrion Details, CompanyType, Blood Product Area Served and Its Competitors
Table 68. Kedrion Blood Product Product Offered
Table 69. Kedrion Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Kedrion Main Business
Table 71. Kedrion Latest Developments
Table 72. LFB Group Details, CompanyType, Blood Product Area Served and Its Competitors
Table 73. LFB Group Blood Product Product Offered
Table 74. LFB Group Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. LFB Group Main Business
Table 76. LFB Group Latest Developments
Table 77. Biotest Details, CompanyType, Blood Product Area Served and Its Competitors
Table 78. Biotest Blood Product Product Offered
Table 79. Biotest Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Biotest Main Business
Table 81. Biotest Latest Developments
Table 82. BPL Details, CompanyType, Blood Product Area Served and Its Competitors
Table 83. BPL Blood Product Product Offered
Table 84. BPL Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. BPL Main Business
Table 86. BPL Latest Developments
Table 87. RAAS Details, CompanyType, Blood Product Area Served and Its Competitors
Table 88. RAAS Blood Product Product Offered
Table 89. RAAS Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. RAAS Main Business
Table 91. RAAS Latest Developments
Table 92. CBPO Details, CompanyType, Blood Product Area Served and Its Competitors
Table 93. CBPO Blood Product Product Offered
Table 94. CBPO Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. CBPO Main Business
Table 96. CBPO Latest Developments
Table 97. Hualan Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 98. Hualan Bio Blood Product Product Offered
Table 99. Hualan Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Hualan Bio Main Business
Table 101. Hualan Bio Latest Developments
Table 102.Tiantan Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 103.Tiantan Bio Blood Product Product Offered
Table 104.Tiantan Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105.Tiantan Bio Main Business
Table 106.Tiantan Bio Latest Developments
Table 107. Shuanglin Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 108. Shuanglin Bio Blood Product Product Offered
Table 109. Shuanglin Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Shuanglin Bio Main Business
Table 111. Shuanglin Bio Latest Developments
Table 112. Boya Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 113. Boya Bio Blood Product Product Offered
Table 114. Boya Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. Boya Bio Main Business
Table 116. Boya Bio Latest Developments
Table 117. Yuanda Shuyang Details, CompanyType, Blood Product Area Served and Its Competitors
Table 118. Yuanda Shuyang Blood Product Product Offered
Table 119. Yuanda Shuyang Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. Yuanda Shuyang Main Business
Table 121. Yuanda Shuyang Latest Developments
Table 122. Weiguang Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 123. Weiguang Bio Blood Product Product Offered
Table 124. Weiguang Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. Weiguang Bio Main Business
Table 126. Weiguang Bio Latest Developments
Table 127. Nanyue Bio Details, CompanyType, Blood Product Area Served and Its Competitors
Table 128. Nanyue Bio Blood Product Product Offered
Table 129. Nanyue Bio Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. Nanyue Bio Main Business
Table 131. Nanyue Bio Latest Developments
Table 132. KM Biologics Details, CompanyType, Blood Product Area Served and Its Competitors
Table 133. KM Biologics Blood Product Product Offered
Table 134. KM Biologics Blood Product Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. KM Biologics Main Business
Table 136. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Blood Product Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Product Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Blood Product Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Blood Product Sales Market Share by Country/Region (2024)
Figure 8. Blood Product Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Blood Product Market Size Market Share byType in 2024
Figure 10. Blood Product in Hospital
Figure 11. Global Blood Product Market: Hospital (2020-2025) & ($ millions)
Figure 12. Blood Product in Retail Pharmacy
Figure 13. Global Blood Product Market: Retail Pharmacy (2020-2025) & ($ millions)
Figure 14. Blood Product in Other
Figure 15. Global Blood Product Market: Other (2020-2025) & ($ millions)
Figure 16. Global Blood Product Market Size Market Share by Application in 2024
Figure 17. Global Blood Product Revenue Market Share by Player in 2024
Figure 18. Global Blood Product Market Size Market Share by Region (2020-2025)
Figure 19. Americas Blood Product Market Size 2020-2025 ($ millions)
Figure 20. APAC Blood Product Market Size 2020-2025 ($ millions)
Figure 21. Europe Blood Product Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Blood Product Market Size 2020-2025 ($ millions)
Figure 23. Americas Blood Product Value Market Share by Country in 2024
Figure 24. United States Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Blood Product Market Size Market Share by Region in 2024
Figure 29. APAC Blood Product Market Size Market Share byType (2020-2025)
Figure 30. APAC Blood Product Market Size Market Share by Application (2020-2025)
Figure 31. China Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 35. India Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Blood Product Market Size Market Share by Country in 2024
Figure 38. Europe Blood Product Market Size Market Share byType (2020-2025)
Figure 39. Europe Blood Product Market Size Market Share by Application (2020-2025)
Figure 40. Germany Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 41.France Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Blood Product Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Blood Product Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Blood Product Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Blood Product Market Size 2026-2031 ($ millions)
Figure 54. APAC Blood Product Market Size 2026-2031 ($ millions)
Figure 55. Europe Blood Product Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Blood Product Market Size 2026-2031 ($ millions)
Figure 57. United States Blood Product Market Size 2026-2031 ($ millions)
Figure 58. Canada Blood Product Market Size 2026-2031 ($ millions)
Figure 59. Mexico Blood Product Market Size 2026-2031 ($ millions)
Figure 60. Brazil Blood Product Market Size 2026-2031 ($ millions)
Figure 61. China Blood Product Market Size 2026-2031 ($ millions)
Figure 62. Japan Blood Product Market Size 2026-2031 ($ millions)
Figure 63. Korea Blood Product Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Blood Product Market Size 2026-2031 ($ millions)
Figure 65. India Blood Product Market Size 2026-2031 ($ millions)
Figure 66. Australia Blood Product Market Size 2026-2031 ($ millions)
Figure 67. Germany Blood Product Market Size 2026-2031 ($ millions)
Figure 68.France Blood Product Market Size 2026-2031 ($ millions)
Figure 69. UK Blood Product Market Size 2026-2031 ($ millions)
Figure 70. Italy Blood Product Market Size 2026-2031 ($ millions)
Figure 71. Russia Blood Product Market Size 2026-2031 ($ millions)
Figure 72. Egypt Blood Product Market Size 2026-2031 ($ millions)
Figure 73. South Africa Blood Product Market Size 2026-2031 ($ millions)
Figure 74. Israel Blood Product Market Size 2026-2031 ($ millions)
Figure 75.Turkey Blood Product Market Size 2026-2031 ($ millions)
Figure 76. Global Blood Product Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Blood Product Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Blood Product Market Size 2026-2031 ($ millions)
Figure 1. Blood Product Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Product Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Blood Product Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Blood Product Sales Market Share by Country/Region (2024)
Figure 8. Blood Product Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Blood Product Market Size Market Share byType in 2024
Figure 10. Blood Product in Hospital
Figure 11. Global Blood Product Market: Hospital (2020-2025) & ($ millions)
Figure 12. Blood Product in Retail Pharmacy
Figure 13. Global Blood Product Market: Retail Pharmacy (2020-2025) & ($ millions)
Figure 14. Blood Product in Other
Figure 15. Global Blood Product Market: Other (2020-2025) & ($ millions)
Figure 16. Global Blood Product Market Size Market Share by Application in 2024
Figure 17. Global Blood Product Revenue Market Share by Player in 2024
Figure 18. Global Blood Product Market Size Market Share by Region (2020-2025)
Figure 19. Americas Blood Product Market Size 2020-2025 ($ millions)
Figure 20. APAC Blood Product Market Size 2020-2025 ($ millions)
Figure 21. Europe Blood Product Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Blood Product Market Size 2020-2025 ($ millions)
Figure 23. Americas Blood Product Value Market Share by Country in 2024
Figure 24. United States Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Blood Product Market Size Market Share by Region in 2024
Figure 29. APAC Blood Product Market Size Market Share byType (2020-2025)
Figure 30. APAC Blood Product Market Size Market Share by Application (2020-2025)
Figure 31. China Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 35. India Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Blood Product Market Size Market Share by Country in 2024
Figure 38. Europe Blood Product Market Size Market Share byType (2020-2025)
Figure 39. Europe Blood Product Market Size Market Share by Application (2020-2025)
Figure 40. Germany Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 41.France Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Blood Product Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Blood Product Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Blood Product Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Blood Product Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Blood Product Market Size 2026-2031 ($ millions)
Figure 54. APAC Blood Product Market Size 2026-2031 ($ millions)
Figure 55. Europe Blood Product Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Blood Product Market Size 2026-2031 ($ millions)
Figure 57. United States Blood Product Market Size 2026-2031 ($ millions)
Figure 58. Canada Blood Product Market Size 2026-2031 ($ millions)
Figure 59. Mexico Blood Product Market Size 2026-2031 ($ millions)
Figure 60. Brazil Blood Product Market Size 2026-2031 ($ millions)
Figure 61. China Blood Product Market Size 2026-2031 ($ millions)
Figure 62. Japan Blood Product Market Size 2026-2031 ($ millions)
Figure 63. Korea Blood Product Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Blood Product Market Size 2026-2031 ($ millions)
Figure 65. India Blood Product Market Size 2026-2031 ($ millions)
Figure 66. Australia Blood Product Market Size 2026-2031 ($ millions)
Figure 67. Germany Blood Product Market Size 2026-2031 ($ millions)
Figure 68.France Blood Product Market Size 2026-2031 ($ millions)
Figure 69. UK Blood Product Market Size 2026-2031 ($ millions)
Figure 70. Italy Blood Product Market Size 2026-2031 ($ millions)
Figure 71. Russia Blood Product Market Size 2026-2031 ($ millions)
Figure 72. Egypt Blood Product Market Size 2026-2031 ($ millions)
Figure 73. South Africa Blood Product Market Size 2026-2031 ($ millions)
Figure 74. Israel Blood Product Market Size 2026-2031 ($ millions)
Figure 75.Turkey Blood Product Market Size 2026-2031 ($ millions)
Figure 76. Global Blood Product Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Blood Product Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Blood Product Market Size 2026-2031 ($ millions)
